These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 25366603)

  • 1. The role of erythropoietin in aneurysmal subarachnoid haemorrhage: from bench to bedside.
    Grasso G; Buemi M; Giambartino F
    Acta Neurochir Suppl; 2015; 120():75-80. PubMed ID: 25366603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnesium in subarachnoid haemorrhage: proven beneficial?
    van den Bergh WM
    Magnes Res; 2009 Sep; 22(3):121-6. PubMed ID: 19780398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of delayed cerebral ischemia after subarachnoid hemorrhage.
    Koenig MA
    Continuum (Minneap Minn); 2012 Jun; 18(3):579-97. PubMed ID: 22810250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin prevents delayed hemodynamic dysfunction after subarachnoid hemorrhage in a randomized controlled experimental setting.
    Güresir E; Vasiliadis N; Konczalla J; Raab P; Hattingen E; Seifert V; Vatter H
    J Neurol Sci; 2013 Sep; 332(1-2):128-35. PubMed ID: 23907045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin in patients with aneurysmal subarachnoid haemorrhage: a double blind randomised clinical trial.
    Springborg JB; Møller C; Gideon P; Jørgensen OS; Juhler M; Olsen NV
    Acta Neurochir (Wien); 2007 Nov; 149(11):1089-101; discussion 1101. PubMed ID: 17876497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentials of magnesium treatment in subarachnoid haemorrhage.
    van den Bergh WM; Dijkhuizen RM; Rinkel GJ
    Magnes Res; 2004 Dec; 17(4):301-13. PubMed ID: 15726906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats.
    Springborg JB; Ma X; Rochat P; Knudsen GM; Amtorp O; Paulson OB; Juhler M; Olsen NV
    Br J Pharmacol; 2002 Feb; 135(3):823-9. PubMed ID: 11834631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia.
    Vergouwen MD; Vermeulen M; Coert BA; Stroes ES; Roos YB
    J Cereb Blood Flow Metab; 2008 Nov; 28(11):1761-70. PubMed ID: 18628782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasospasm: my first 25 years-what worked? what didn't? what next?
    Loch Macdonald R
    Acta Neurochir Suppl; 2015; 120():1-10. PubMed ID: 25366591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIMALAIA (Hypertension Induction in the Management of AneurysmaL subArachnoid haemorrhage with secondary IschaemiA): a randomized single-blind controlled trial of induced hypertension vs. no induced hypertension in the treatment of delayed cerebral ischemia after subarachnoid hemorrhage.
    Gathier CS; van den Bergh WM; Slooter AJ;
    Int J Stroke; 2014 Apr; 9(3):375-80. PubMed ID: 23692645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin for the Treatment of Subarachnoid Hemorrhage: A Feasible Ingredient for a Successful Medical Recipe.
    Grasso G; Tomasello G; Noto M; Alafaci C; Cappello F
    Mol Med; 2016 Mar; 21(1):979-987. PubMed ID: 26581085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage.
    Grasso G; Buemi M; Alafaci C; Sfacteria A; Passalacqua M; Sturiale A; Calapai G; De Vico G; Piedimonte G; Salpietro FM; Tomasello F
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5627-31. PubMed ID: 11943864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of cerebral autoregulation following subarachnoid haemorrhage.
    Budohoski KP; Czosnyka M; Kirkpatrick PJ; Smielewski P; Steiner LA; Pickard JD
    Nat Rev Neurol; 2013 Mar; 9(3):152-63. PubMed ID: 23419369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage Part I: Incidence and effects.
    Dorsch NW; King MT
    J Clin Neurosci; 1994 Jan; 1(1):19-26. PubMed ID: 18638721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.
    Hänggi D; Beseoglu K; Turowski B; Steiger HJ
    Clin Neurol Neurosurg; 2008 Sep; 110(8):784-90. PubMed ID: 18554777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative measures to improve outcome after subarachnoid hemorrhage-revisiting the concept of secondary brain injury.
    Steiger HJ; Beez T; Beseoglu K; Hänggi D; Kamp MA
    Acta Neurochir Suppl; 2015; 120():211-6. PubMed ID: 25366626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal application of the nimodipine slow-release microparticle system eg-1962 for prevention of delayed cerebral ischemia and improvement of outcome after aneurysmal subarachnoid hemorrhage.
    Etminan N; Macdonald RL; Davis C; Burton K; Steiger HJ; Hänggi D
    Acta Neurochir Suppl; 2015; 120():281-6. PubMed ID: 25366637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Subarachnoid hemorrhage in young patients].
    Naggara O; Nataf F
    Rev Prat; 2013 Sep; 63(7):951-9. PubMed ID: 24167898
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.